BMY's growth-driving portfolio increased 17% year-over-year, prompting an upward revision in 2025 revenue guidance and ...

Novartis will acquire Avidity Biosciences for $12 billion at $72 per share, gaining its RNA-targeting platform and neuroscience pipeline as Avidity spins off its precision cardiology programs into a ...

The University at Albany and Virginia Commonwealth University were awarded a $6.5 million NIH grant to establish a federal ...

An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

Epitranscriptomics, the study of dynamic co- or post-transcriptional modifications on RNA, has emerged as a vibrant field in ...

The 55th Lewis S. Rosenstiel Award for Distinguished Work in Basic Medical Research has been awarded to professor Steven ...

Biostate AI, a pioneer in AI-driven molecular diagnostics, today announced that its Indian subsidiary Bayosthiti AI has partnered with Narayana Health, one of the world's largest cardiac care networks ...

As we enter entrepreneurship month this November, we’re celebrating the professors and alumni who are fueling job creation ...

Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...

ETH Zurich scientists have created “MetaGraph,” a revolutionary DNA search engine that functions like Google for genetic data. By compressing global genomic datasets by a factor of 300, it allows ...

Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...